Nós isolamos e seqüenciamos genes que codificam Catepsina L-like em diversos isolados de T.rangeli de humano, mamíferos silvestres e Rhodnius spp., do centro e sul da América. Análises filogenéticas de seqüências que codificam a proteína madura de T. rangeli, outras espécies de Trypanosoma e Leishmania e duas espécies de bodonídeos, posicionaram T.rangeli próximo a T.cruzi de acordo com a ordem de divergência determinada em filogenias baseadas em SSUrDNA. Uma análise de 17 seqüências do domínio catalítico de CatL-like de isolados representativos da diversidade filogenética e distribuição geográfica de T. rangeli, apoiaram as mesmas linhagens filogenéticas previamente definidas. Seqüências do gene CatL-like também foram usados para padronizar ensaios de PCR para diagnóstico de T. cruzi e T. rangeli. Além disso, um método de genotipagem por PCR multiplex segregou os isolados de T. rangeli nas principais linhagens previamente estabelecidas. Este é o primeiro estudo usando um gene codificador de proteína para comparar isolados de T. rangeli de linhagens distintas. / We have isolated and sequenced genes encoding cathepsin L-like (CatL-like) cysteine proteases from isolates of T. rangeli from human, wild mammals and Rhodnius spp., from Central and South America. Phylogenetic analysis of sequences encoding the mature CatL-like enzymes from T. rangeli (Rangelipain), other Trypanosoma and Leishmania species, and two species of bodonids, positioned T. rangeli closest to T. cruzi corroborating the same order of divergence showed in phylogenies based on SSU rDNA. Analysis of 17 sequences of the catalytic domains of CatL-like genes isolates representative of the phylogenetic diversity and geographical range of T.rangeli supported previously defined phylogenetic lineages. Sequences of CatL-like genes were used to standardize PCR assays for the diagnosis of T. rangeli and T. cruzi, and a genotyping method of multiplex-PCR distributed of isolates of T. rangeli in the major phylogenetic lineages previously established. This is the first study using protein-encoding genes to compare isolates from T. rangeli of distinct lineages.

O tratamento para a Leucemia Linfoblástica Aguda LLA utiliza, entre outros fármacos, a enzima L-asparaginase (ASNase) proveniente da bactéria Escherichia coli. Reações imunológicas estão entre os problemas do tratamento com ASNase, e a formação de anticorpos contra essa proteína pode impedir o sucesso no tratamento. Duas cisteíno proteases lisossomais estão relacionadas com a degradação de ASNase nos seres humanos, a Catepsina B (CTSB) e Asparagina Endopeptidase (AEP). Em estudos prévios do nosso grupo obteve-se mutantes de ASNase resistentes a degradação por CTSB e/ou AEP in vitro. Nesse trabalho avaliamos essas mutantes quanto a sua citotoxicidade em linhagens celulares de leucemia e conduzimos estudos in vivo, aplicando as proteoformas de ASNases em camundongos Balb C para avaliar a atividade asparaginase sérica das enzimas ao longo do tempo, bem como obter informações sobre a formação de anticorpos contra essas proteoformas. Nos ensaios de citotoxicidade, duas das proteoformas testadas tiveram efeito citotóxico semelhante a forma selvagem, enquanto uma outra proteoforma tem a citotoxicidade sensivelmente reduzida. Já nos ensaios in vivo, uma proteoforma demonstrou meia vida sérica maior da atividade asparaginásica, e duas proteoformas causaram reduzida formação de anticorpos. Juntos, esses resultados colaboram para a obtenção de uma nova geração de ASNases com melhor biodisponibilidade, e efeitos adversos reduzidos, gerando a possibilidade de menores doses e frequência de aplicações. / The Treatment for Acute Lymphoblastic Leukemia (ALL) includes the biopharmaceutical L-asparaginase (ASNase) from Escherichia coli. Immunological reactions are among the problems of treatment using ASNase, and the antibodies formation protein may prevent success in treatment. Lysosomal cysteine proteases are related to ASNase degradation, Cathepsin B (CTSB) and Asparagine Endopeptidase (AEP). In previous studies, ASNase mutants resistant to CTSB and / or AEP degradation in vitro were obtained. In this work, mutants were evaluated in cytotoxicity in ALL cell lines and, in vivo studies, applying doses of the wild and mutant ASNases in Balb C mice to evaluate serum asparaginase activity of the enzymes over time, as well as to obtain information on the formation of antibodies against these proteoforms. Regarding to the cytotoxicity, two proteoforms among the tested had similar cytotoxicity than the wild-type. While another proteoform had the cytotoxicity severely reduced. One proteoform have demonstrated greater serum half-life of asparaginase activity, while two other mutants caused reduced antibody formation. Together, these results collaborate to obtain a new generation of ASNases with increased bioavailability and reduced side effects, generating the possibility of lower doses and frequency of applications.

O tratamento para a Leucemia Linfoblástica Aguda LLA utiliza, entre outros fármacos, a enzima L-asparaginase (ASNase) proveniente da bactéria Escherichia coli. Reações imunológicas estão entre os problemas do tratamento com ASNase, e a formação de anticorpos contra essa proteína pode impedir o sucesso no tratamento. Duas cisteíno proteases lisossomais estão relacionadas com a degradação de ASNase nos seres humanos, a Catepsina B (CTSB) e Asparagina Endopeptidase (AEP). Em estudos prévios do nosso grupo obteve-se mutantes de ASNase resistentes a degradação por CTSB e/ou AEP in vitro. Nesse trabalho avaliamos essas mutantes quanto a sua citotoxicidade em linhagens celulares de leucemia e conduzimos estudos in vivo, aplicando as proteoformas de ASNases em camundongos Balb C para avaliar a atividade asparaginase sérica das enzimas ao longo do tempo, bem como obter informações sobre a formação de anticorpos contra essas proteoformas. Nos ensaios de citotoxicidade, duas das proteoformas testadas tiveram efeito citotóxico semelhante a forma selvagem, enquanto uma outra proteoforma tem a citotoxicidade sensivelmente reduzida. Já nos ensaios in vivo, uma proteoforma demonstrou meia vida sérica maior da atividade asparaginásica, e duas proteoformas causaram reduzida formação de anticorpos. Juntos, esses resultados colaboram para a obtenção de uma nova geração de ASNases com melhor biodisponibilidade, e efeitos adversos reduzidos, gerando a possibilidade de menores doses e frequência de aplicações. / The Treatment for Acute Lymphoblastic Leukemia (ALL) includes the biopharmaceutical L-asparaginase (ASNase) from Escherichia coli. Immunological reactions are among the problems of treatment using ASNase, and the antibodies formation protein may prevent success in treatment. Lysosomal cysteine proteases are related to ASNase degradation, Cathepsin B (CTSB) and Asparagine Endopeptidase (AEP). In previous studies, ASNase mutants resistant to CTSB and / or AEP degradation in vitro were obtained. In this work, mutants were evaluated in cytotoxicity in ALL cell lines and, in vivo studies, applying doses of the wild and mutant ASNases in Balb C mice to evaluate serum asparaginase activity of the enzymes over time, as well as to obtain information on the formation of antibodies against these proteoforms. Regarding to the cytotoxicity, two proteoforms among the tested had similar cytotoxicity than the wild-type. While another proteoform had the cytotoxicity severely reduced. One proteoform have demonstrated greater serum half-life of asparaginase activity, while two other mutants caused reduced antibody formation. Together, these results collaborate to obtain a new generation of ASNases with increased bioavailability and reduced side effects, generating the possibility of lower doses and frequency of applications.

The yeasts Pichia pastoris and Kluyveromyces lactis were used to express several recombinant human proteins for further biochemical characterization. Two substitution variants of recombinant human enteropeptidase light chain (rhEPL) were engineered to modify the extended substrate specificity of this serine protease. Both were secreted as active enzymes in excess of 1.7 mg/L in P. pastoris fermentation broth. The substitution variant rhEPL R96Q showed significantly reduced specificities for the preferred substrate sequences DDDDK and DDDDR; however, the rhEPL Y174R variant displayed improved specificities for these substrate sequences relative to all other reported variants of this enzyme. The neutrophil serine proteases human cathepsin G (hCatG) and human neutrophil elastase (HNE) were expressed in P. pastoris and HNE was also expressed in K. lactis. The recombinant variants rhCatG and rHNE, with intact C-terminal extensions, were expressed as fusion proteins with the soluble heme-binding domain of cytochrome B5 (CytB5) and an N-terminal hexahistidine (6xHis) tag for purification. The CytB5 domain was linked to the native N-termini of active rhCatG and rHNE by the EPLcleavable substrate sequence DDDDK~I, where ~ is the sessile bond. These fusion proteins were directed for secretion. The yeast P. pastoris expressed up to 3.5 mg/L of EPL-activable rHNE in fermentation broth; however, only 200 μg/L of rhCatG could be produced by this method. Recombinant expression in K. lactis never surpassed 100 μg/L of activable rHNE. The CytB5 fusion domain was present in the heme-bound form, conferring a red color and 410 nm absorbance peak to solutions containing the fusion proteins. This absorbance pattern was most readily visible during the purification of CytB5-rHNE from P. pastoris. Human C-reactive protein (hCRP) and the substitution variant CRP E42Q were expressed in recombinant form and secreted by P. pastoris. Both products were found to bind phosphocholine (PCh) in the same manner as native hCRP. Difficulties encountered during purification revealed that wild type recombinant CRP (rCRP) was produced at 2 different molecular masses. The P. pastoris recombinant expression system yielded better results than K. lactis. Bioreactor-scale fermentation in a 5 L vessel facilitated expression and characterization of these recombinant proteins.

La dégradation protéolytique du collagène de type II est considérée comme étant un facteur majeur dans le processus irréversible de dégradation de la matrice cartilagineuse lors d’ostéoarthrose. Outre les collagénases de la famille des métaloprotéinases de la matrice (MMP-1, -8, -13), la cathepsine K est parmi les seules enzymes susceptibles de dégrader la triple hélice intacte du collagène de type II, devenant ainsi un élément pertinent pour les recherches sur l’ostéoarthrose. L’objectif à court terme de notre étude consiste en l’identification et la caractérisation de sites de clivage spécifiques de la cathepsine K sur le collagène de type II équin. La technique d’électrophorèse SDS-PAGE 1D permet la visualisation des produits de digestion et la validation des résultats de la caractérisation moléculaire des fragments protéolytiques. La caractérisation est réalisée en combinant la digestion trypsique précédant l’analyse HPLC-ESI/MS. Les résultats ont permis d’établir les sites, présents sur la carte peptidique de la molécule de collagène de type II équin, des 48 résidus prolines (P) et 5 résidus lysines (K) supportant une modification post-traductionnelle. De plus, 6 fragments majeurs, différents de ceux produits par les MMPs, sont observés par SDS-PAGE 1D puis confirmés par HPLC-ESI/MS, correspondant aux sites suivants : F1 [G189-K190], F2 [G252-P253], F3 [P326-G327], F4 [P428-G429], F5 [P563-G564] et F6 [P824-G825]. Le fragment F1 nouvellement identifié suggère un site de clivage différent de l’étude antérieure sur le collagène de type II bovin et humain. L’objectif à long terme serait le développement d’anticorps spécifiques au site identifié, permettant de suivre l’activité protéolytique de la cathepsine K par immunohistochimie et ÉLISA, dans le cadre du diagnostic de l’ostéoarthrose. / The proteolytic degradation of type II collagen is believed to be mainly an irreversible event in the process of cartilage matrix degradation in osteoarthritis. Cathepsin K is the most active enzyme protease outside the matrix metalloproteinase (MMP) family (MMP 13, -8, -1) capable of degrading the intact triple helical type II collagen. The short term objective of our study was to characterize the specific cleavage sites of CK on type II collagen. Our long term goal is to develop antibodies specific to these sites to develop biomarkers to detect it’s cleavage, for the early diagnosis of OA. Thus, in order to achieve our first goal, Cathepsin K cleavage of equine type II collagen was first examined by SDS-PAGE electrophoresis. Molecular characterization of proteolytic fragments, and therefore cleavage sites, was performed using tryptic digestion followed by LC-ESI/MS analysis to establish a comprehensive peptide map which was used as a template to identify specific proteolytic cleavage by cathepsin K. Comprehensive peptide mapping provided information on post-translational modifications and permitted the identification of 48 proline (P) and 5 lysine (K) residues that were subject to post translational modification. Six major fragments were observed on 1D SDS-PAGE and confirmed by HPLC-ESI/MS including F1 [189-190], F2 [252-253], F3 [326-327], F4 [428-429], F5 [563-564] and F6 [824-825]. The observed F1 fragment showed that cleavage was three residues N-terminal to the site reported previously for bovine type II collagen. These new findings will be used to develop new analytical methods to quantify biomarkers associate to equine type II collagen degradation in osteoarthritis patient and/or to support the development of new treatments.

No description available.

Diss. (sammanfattning) Linköping : Linköpings universitet, 2008. / Härtill 4 uppsatser.

The intracellular proteolysis of ingested meal plays an essential role in tick development. The thesis focuses on the factors influencing the expressions and activities of digestive enzymes in Ixodes ricinus females during the feeding and post-feeding period. We have revealed the effect of fertilization on blood feeding and digestion. The females cannot reach the rapid engorgement phase without being fertilized. The rate of mated females in the nature proved the presumption that mating can occur even off the host. Implementation of in vitro feeding technique further extended our current knowledge about tick digestive apparatus. Adult females were fed on hemoglobin-rich and hemoglobin-poor diet and the mRNA expression levels of digestive proteases were determined. In line with obtained data, we assumed that albuminolysis is conducted by the same or similar pathway as hemoglobinolysis. The gene silencing method and protein immuno-detection were used to unequivocally identify the isoforms of 'early expressed' IrCL1 and 'late expressed' IrCL3 isoform of cathepsin L.

Made available in DSpace on 2014-12-17T14:03:25Z (GMT). No. of bitstreams: 1 GiocondaEDDM.pdf: 827312 bytes, checksum: dd690ec78d2921013aa0e24b334bac19 (MD5) Previous issue date: 2007-12-14 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / In this study, a BCR-ABL expressing human chronic myelogenous leukaemia cell line (K562) was used to investigate the antitumoral potential of a novel lectin (CvL) purified from the marine sponge Cliona varians. CvL inhibited the growth of K562 cells with an IC50 value of 70 g/ml, but was ineffective to normal human peripheral blood lymphocytes in the same range of concentrations tested (180 g/ml). Cell death occurred after 72 h of exposure to the lectin and with sign of apoptosis as analysed by DAPI staining. Investigation of the possible effectors of this process showed that cell death occurred in the presence of Bcl-2 and Bax expression, and involved a caspase-independent pathway. Confocal fluorescence microscopy indicated a major role for the lysosomal protease cathepsin B in mediating cell death. Accordingly, pre-incubation of K562 cells with the cathepsin inhibitor L-trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64) abolished the cytotoxic effect of CvL. Furthermore, we found upregulation of tumor necrosis factor receptor 1 (TNFR1) and down-modulation of p65 subunit of nuclear factor kappa B (NFB) expression in CvL-treated cells. These effects were accompanied by increased levels of p21 and downmodulation of pRb, suggesting that CvL is capable of cell cycle arrest. Collectively, these findings suggest that cathepsin B acts as death mediator in CvL-induced cytotoxicity possibly in a still uncharacterized connection with the membrane death receptor pathway / Neste trabalho, a linhagem K562 de c?lulas de leucemia miel?ide cr?nica, expressando a prote?na oncog?nica BCR-ABL, foi usada como modelo para investigar a atividade antitumoral da lectina CvL purificada da esponja marinha Cliona varians. CvL inibiu o crescimento de c?lulas K562 com um IC50 de 70 g/mL, mas n?o afetou a viabilidade celular de linf?citos normais de sangue perif?rico humano no mesmo intervalo de concentra??es testadas (1 80 g/mL). A morte celular ocorreu ap?s 72 horas de exposi??o ? lectina e com altera??es nucleares t?picas de apoptose como analisado pela fluoresc?ncia de DAPI. Investiga??o dos poss?veis efetores deste processo mostrou que a morte celular ocorreu sem ativa??o de caspases e na presen?a de express?es aumentadas de Bcl-2 e Bax. O fato de CvL desencadear a libera??o de catepsina B, como evidenciado pela microscopia de fluoresc?ncia, e do inibidor E-64 bloquear completamente a morte celular induzida por CvL, sugerem papel central dessa protease lisossomal na ativa??o de uma via alternativa de morte celular. CvL tamb?m induziu o aumento de express?o do receptor de morte TNFR-1 e a diminui??o dos n?veis de NFκB. Estes efeitos foram acompanhados pelo aumento significativo na express?o de p21 e pela modula??o negativa de pRb, mostrando que CvL foi capaz de bloquear a progress?o do ciclo celular. Juntos, estes dados sugerem que catepsina B age como mediador da citotoxicidade induzida por CvL possivelmente atrav?s de uma conex?o ainda n?o caracterizada com a via dos receptores de morte

A catepsina L, uma cisteína proteinase da família da papaína, é a principal proteinase digestiva do besouro Tenebrio molitor. Estudos anteriores do nosso grupo mostraram que existem três catepsinas L no intestino médio do T. molitor, uma delas é lisossômica (CAL 1) e as outras duas são digestivas (CAL 2 e CAL 3). As estruturas 3D das enzimas digestivas foram recentemente elucidadas. Com o objetivo de estudar em detalhes as propriedades das enzimas digestivas, CAL 3 foi expressa como um zimógeno em E. coli, purificada por cromatografia de afinidade e autoativada em meio ácido. Foram realizados ensaios de atividade com 63 peptídeos FRET derivados da sequência Abz-KLRSSKQ-EDDnp em um espectrofluorímetro termostatizado a 30 ºC, monitorando-se continuamente a variação de fluorescência em 320 nm (λex) e 420 nm (λem). Os parâmetros kcat e KM obtidos foram utilizados na determinação da hidrofobicidade dos subsítios (H) e da função de cada subsítio através da razão das energias livres de ativação do complexo enzima-substrato (ΔG‡T) e de ligação da enzima com o substrato (ΔGs). Os resultados mostram que o subsítio S2 está envolvido prioritariamente em catálise e é bastante seletivo para substratos com resíduos hidrofóbicos em P2. Esse subsítio é o mais hidrofóbico dentre os analisados, encontrando-se num bolsão localizado no interior da enzima. O subsítio S\'2, por outro lado, é o que apresentou a menor especificidade dentre os analisados. Este subsítio está envolvido prioritariamente na ligação com o substrato e se localiza na superfície da enzima, o que pode facilitar a acomodação de diferentes cadeias laterais em P\'2 do substrato, não oferecendo muitas restrições espaciais. O subsítio S1, hidrofílico, não é muito seletivo, o que pode ser consequência de sua localização na superfície da enzima. Esse subsítio está prioritariamente envolvido na ligação com o substrato. O subsítio S\'1, assim como S1, está localizado na superfície da enzima, é hidrofílico e não muito seletivo. No entanto, esse subsítio tem papel na catálise além de atuar na ligação do substrato. Numa análise inicial da estrutura 3D deste subsítio, sua função catalítica foi atribuída à presença de parte da cavidade oxiânica. Uma enzima com mutação no resíduo W187, pertencente à cavidade oxiânica e a S\'1, foi produzida e purificada, no entanto essa enzima não apresentou atividade. Uma análise mais aprofundada mostrou que a falta de atividade pode ser atribuída ao fato do resíduo de aminoácido mutado fazer parte de um cluster aromático essencial à estabilização da tríade catalítica. Os dados obtidos na caracterização de S\'1 e S\'2 permitem inferir que a acilação é o passo limitante da reação da CAL 3. Além disso, os resultados deste trabalho mostram que o conceito de hidrofobicidade de subsítios proposto anteriormente pelo grupo parece ser aplicável a subsítios que apresentem especificidades mais restritas. / Cathepsin L, a cysteine proteinase of the papain family, is the major digestive proteinase in the beetle Tenebrio molitor. Previous studies of our group showed that there are three cathepsins L in T. molitor midgut, one is lysosomal (CAL1) and two are digestive (CAL2 and CAL3). The 3D structures of the digestive enzymes were recently elucidated. With the aim to study in details the digestive enzymes specificities, CAL3 was expressed in E. coli as a zymogen, purified by affinity chromatography and autoactivated in acid conditions. Activity assays were performed in a thermostated spectrofluorometer at 30 ºC with 63 FRET peptides derived from the lead sequence Abz-KLRSSKQ-EDDnp, continuously monitoring the fluorescence changes at 320 nm (λex) and 420 nm (λem). The parameters kcat and KM were used in the determination of subsite hydrophobicity (H) and subsite role based on the ratio of complex enzyme-substrate activation energy (ΔG‡T) and free energy of substrate binding (ΔGs). The data obtained suggest that the S2 is mainly involved in catalysis and is very selective to substrates with hydrophobic residues in P2. This subsite is the most hydrophobic among the analyzed and is located in a pocket in the enzyme interior. S\'2, on the other hand, is the less selective subsite and is mainly involved in substrate binding and is located on the enzyme surface, what can ease the accommodation of different side chains located in P\'2 by not imposing many spatial restrictions. S1, is hydrophilic and not very selective, what may be a consequence of its location on the enzyme surface. This subsite is mainly involved in substrate binding. S\'1, just like S1, is located on the enzyme surface, is hydrophilic and not very selective. However this subsite has a role in catalysis besides the role in substrate binding. In an initial 3D structure analysis its catalytic function was attributed to the presence of a part of the oxyanion hole. An enzyme with mutation in the residue W187, which apparently belonged both to the oxyanion hole and S\'1, was produced and purified, but this enzyme was inactive. A better analysis showed that the lack of activity can be attributed to the fact that the mutated residue belongs to an aromatic cluster that is essential to the catalytic triad stabilization. The data obtained in S\'1 and S\'2 characterization suggest that acylation is the limiting step in CAL 3 reaction. The results presented in this work support the concept of subsite hydrophobicity previously proposed by our group, which seems to be true to subsites with more restrict specificities